Krempa David 4
4 · Eton Pharmaceuticals, Inc. · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Award
Restricted Stock Units
2024-10-02+42,088→ 861,374 total→ Common Stock (42,088 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F2]The restricted stock units vest in four equal annual installments beginning October 2, 2025, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.